Home › Schizophrenia › Michigan
Schizophrenia clinical trials in Michigan
4 studies for Schizophrenia are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0152, Bloomfield Hills
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 6, 2026 · NCT07424404Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Neurobehavioral Medicine Group, Bloomfield Hills
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0014, Bloomfield Township
- Local Institution - 0036, Detroit
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07379827A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Ann Arbor
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 15, 2026 · NCT07459647From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.